Renal replacement therapy in ADPKD patients: a 25-year survey based on the Catalan registry.

Background: Some 7-10% of patients on replacement renal therapy (RRT) are receiving it because of autosomal dominant polycystic kidney disease (ADPKD). The age at initiation of RRT is expected to increase over time.

Methods: Clinical data of 1,586 patients (7.

The effects of hyperlipidaemia on graft and patient outcome in renal transplantation.

Hyperlipidaemia is a frequent complication after renal transplantation. As to whether total cholesterol (TC) and triglyceride levels are risk factors for cardiovascular disease and graft survival is controversial. The prevalence of hypercholesterolaemia in the transplanted population in Spain has increased over the years, going from 38.